These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16253356)

  • 1. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project.
    Lane DA; Ponsford J; Shelley A; Sirpal A; Lip GY
    Int J Cardiol; 2006 Jun; 110(3):354-8. PubMed ID: 16253356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).
    Smith DE; Xuereb CB; Pattison HM; Lip GY; Lane DA
    BMC Cardiovasc Disord; 2010 May; 10():21. PubMed ID: 20487528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project.
    Lip GY; Kamath S; Jafri M; Mohammed A; Bareford D
    Stroke; 2002 Jan; 33(1):238-42. PubMed ID: 11779916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
    Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
    Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.
    Zweiker D; Zweiker R; Winkler E; Roesch K; Schumacher M; Stepan V; Krippl P; Bauer N; Heine M; Reicht G; Zweiker G; Sprenger M; Watzinger N
    BMJ Open; 2017 Sep; 7(9):e018242. PubMed ID: 28951417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial.
    Clarkesmith DE; Pattison HM; Lip GY; Lane DA
    PLoS One; 2013; 8(9):e74037. PubMed ID: 24040156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Censis survey on atrial fibrillation awareness in the general population and among general practitioners and affected patients in Italy].
    Gensini GF; Di Pasquale G; Vaccaro CM; Riva L; Iori I; Nozzoli C; Pengo V; Ricci S; Santini M; Toni D
    G Ital Cardiol (Rome); 2014 Jan; 15(1):37-43. PubMed ID: 24503733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire.
    Desteghe L; Engelhard L; Raymaekers Z; Kluts K; Vijgen J; Dilling-Boer D; Koopman P; Schurmans J; Dendale P; Heidbuchel H
    Int J Cardiol; 2016 Nov; 223():906-914. PubMed ID: 27589038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.
    Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
    Heart Rhythm; 2015 Aug; 12(8):e105-13. PubMed ID: 25981149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].
    Fareau S; Baumstarck K; Farcet A; Molines C; Auquier P; Retornaz F
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Mar; 13(1):45-54. PubMed ID: 25786423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events.
    Alphonsa A; Sharma KK; Sharma G; Bhatia R
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):668-72. PubMed ID: 25577429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    BMC Med Educ; 2016 Jan; 16():9. PubMed ID: 26758627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.
    McCrory DC; Matchar DB; Samsa G; Sanders LL; Pritchett EL
    Arch Intern Med; 1995 Feb; 155(3):277-81. PubMed ID: 7832599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.